A growing library of the omega-3 research we're following — summarized and categorized so you can find what matters to you.
A modified EPA compound lowered severe triglyceride levels by about 32% more than placebo over 4 weeks and also improved fasting blood sugar markers.
In a rat study, omega-3 pretreatment reduced liver tissue damage and favorably shifted inflammatory and protective (SIRT1/HO-1) markers during induced endotoxemia.
In a rodent model, omega-3 supplementation partially offset neurodevelopmental and inflammatory changes caused by combined prenatal opioid exposure and chronic stress.
A secondary analysis of the ADORE trial examined whether matching DHA dose to a woman's FADS gene variant could help reduce rates of early preterm birth and prolonged gestation.
In a mouse neuroblastoma model, high-dose omega-6 (ARA) accelerated tumor growth while high-dose omega-3 (DHA) caused tumor shrinkage or regression via competing lipid signaling pathways.
In obese rats, krill oil supplementation lowered blood cholesterol and reversed diet-induced changes in sortilin and TNF-α levels in the liver and fat tissue.